The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Expression of NKG2D immunoreceptor ligands on tumour cells is believed to inhibit tumour growth through engaging NKG2D-expressing immune cells. Here, the authors show that in a model of liver cancer the NKG2D/NKG2D-ligand pathway can also promote tumour formation by sustaining an inflammatory enviro...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19101936214342739334b5deafccc5f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:19101936214342739334b5deafccc5f2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:19101936214342739334b5deafccc5f22021-12-02T15:37:02ZThe immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma10.1038/ncomms139302041-1723https://doaj.org/article/19101936214342739334b5deafccc5f22017-01-01T00:00:00Zhttps://doi.org/10.1038/ncomms13930https://doaj.org/toc/2041-1723Expression of NKG2D immunoreceptor ligands on tumour cells is believed to inhibit tumour growth through engaging NKG2D-expressing immune cells. Here, the authors show that in a model of liver cancer the NKG2D/NKG2D-ligand pathway can also promote tumour formation by sustaining an inflammatory environment.Sam SheppardJoana GuedesAnna MrozAnastasia-Maria ZavitsanouHiromi KudoStephen M. RotheryPanagiotis AngelopoulosRobert GoldinNadia GuerraNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Sam Sheppard Joana Guedes Anna Mroz Anastasia-Maria Zavitsanou Hiromi Kudo Stephen M. Rothery Panagiotis Angelopoulos Robert Goldin Nadia Guerra The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
description |
Expression of NKG2D immunoreceptor ligands on tumour cells is believed to inhibit tumour growth through engaging NKG2D-expressing immune cells. Here, the authors show that in a model of liver cancer the NKG2D/NKG2D-ligand pathway can also promote tumour formation by sustaining an inflammatory environment. |
format |
article |
author |
Sam Sheppard Joana Guedes Anna Mroz Anastasia-Maria Zavitsanou Hiromi Kudo Stephen M. Rothery Panagiotis Angelopoulos Robert Goldin Nadia Guerra |
author_facet |
Sam Sheppard Joana Guedes Anna Mroz Anastasia-Maria Zavitsanou Hiromi Kudo Stephen M. Rothery Panagiotis Angelopoulos Robert Goldin Nadia Guerra |
author_sort |
Sam Sheppard |
title |
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
title_short |
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
title_full |
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
title_fullStr |
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
title_full_unstemmed |
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
title_sort |
immunoreceptor nkg2d promotes tumour growth in a model of hepatocellular carcinoma |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/19101936214342739334b5deafccc5f2 |
work_keys_str_mv |
AT samsheppard theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT joanaguedes theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT annamroz theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT anastasiamariazavitsanou theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT hiromikudo theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT stephenmrothery theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT panagiotisangelopoulos theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT robertgoldin theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT nadiaguerra theimmunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT samsheppard immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT joanaguedes immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT annamroz immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT anastasiamariazavitsanou immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT hiromikudo immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT stephenmrothery immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT panagiotisangelopoulos immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT robertgoldin immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma AT nadiaguerra immunoreceptornkg2dpromotestumourgrowthinamodelofhepatocellularcarcinoma |
_version_ |
1718386217597272064 |